about
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisCerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?Modifiable factors influencing relapses and disability in multiple sclerosis.Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial.A rapid screening tool for fatigue impact in multiple sclerosis.Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.Graph theoretical analysis indicates cognitive impairment in MS stems from neural disconnection.Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis.Multiparity in women with multiple sclerosis causes less long-term disability: yes."How to conquer a mountain with multiple sclerosis". How a climbing expedition to Machu Picchu affects the way people with multiple sclerosis experience their body and identity: a phenomenological analysis.The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial.Self-reported levels of education and disability progression in multiple sclerosis.A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls.Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.Relative contribution of cognitive and physical disability components to quality of life in MS.Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.Self-reported health promotion and disability progression in multiple sclerosis.Reduced information processing speed as primum movens for cognitive decline in MS.Definition, prevalence and predictive factors of benign multiple sclerosis.Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.Does including the full CVLT-II and BVMT-R improve BICAMS? Evidence from a Belgian (Dutch) validation study.Sperm-associated antigen 16 is a novel target of the humoral autoimmune response in multiple sclerosis.Electronic visual analogue scales for pain, fatigue, anxiety and quality of life in people with multiple sclerosis using smartphone and tablet: a reliability and feasibility study.Long-term effects of childbirth in MS.The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.Within-session practice effect on paced auditory serial addition test in multiple sclerosis.Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial.Measuring activity patterns using actigraphy in multiple sclerosis.The effect of task modality and stimulus frequency in paced serial addition tests on functional brain activity.Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study.Development of the Arm Function in Multiple Sclerosis Questionnaire-Short Form (AMSQ-SF): A static 10-item versionThe Arm Function in Multiple Sclerosis Questionnaire (AMSQ): development and validation of a new tool using IRT methodsCirculating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factorsAlcohol, coffee, fish, smoking and disease progression in multiple sclerosisReplication of KIF21B as a susceptibility locus for multiple sclerosisProxy ratings from multiple sources: disagreement on the impact of multiple sclerosis on daily life
P50
Q24635370-8FE74B84-1765-4740-B34E-D259E4AEA5A5Q27027921-FA709D30-F7C8-4F29-99DA-C7FE232FB5BFQ33581753-FE0E64A0-F501-4959-AA16-3A5BC685AC22Q33747494-625B6444-3231-422A-ADBA-4FB33499E979Q34101885-7CCA3022-7633-4430-A504-54824B29F077Q35053381-42ED7ABC-56F0-40E9-A182-33BD17585DBDQ36753462-312756B8-6264-4A13-B165-440872544F22Q37594808-FC95B453-95FD-437C-91DE-30E1FA38207DQ37597918-E4F2D253-441A-4012-ADFA-4E33137FD4ABQ38123575-427A9B64-C9E7-4E72-BE59-0C4336B167A8Q38262636-EDC0995B-423F-423A-A424-ACA618CE69CBQ38562270-F19352E1-38FD-442F-86FC-09867678D8BBQ38866881-353B5E85-2055-45F7-9A2C-8E05512ACAB0Q40529940-5CE92A3E-A34E-4E4F-BEAE-832E0BDD2F4DQ41369774-2C28C88E-2BCF-46DB-93B8-2F1D20D34315Q42214016-7EF754C5-2F56-49C7-A16F-7213A87241D7Q42665193-0AC2E0B7-3C1D-4DF7-8644-878208E5A233Q43496036-594328AB-8B2A-4A1B-9980-8040069BA70BQ46028028-49CEE6AE-2803-4D73-837F-8A3978779FE4Q46147814-295CF166-D61E-4AFD-8BF1-C04735850E9BQ46388846-89AA4FEE-56A5-4A49-865B-B6B5B66E72FEQ46788130-8C9321F8-6EFB-4B53-8DAB-46806E7EDB9DQ47116223-6BBD9798-62B5-4B93-A5C4-0E1F1BB21085Q47680564-7907E320-8E38-4831-AD90-D94F8C08918BQ48555465-B2A2B64A-FF8D-4319-80DC-81326EE7D731Q48623906-2768B354-0C84-4B1E-9A0C-FBF8C52F722CQ49072204-A996209C-CADF-41AA-9900-BB800D40F759Q51601366-5FCA0DA7-123C-4111-8D73-E50A255EF261Q51832542-3730AC66-76B6-49C0-B09F-2C512E25924FQ51899026-F1DC9110-0E89-4053-B786-FB86A4A79889Q51901629-F9FB935D-331A-443C-A98E-1B7D0315B6C6Q51904512-1BD74FC3-C9E7-49E5-9D67-0ABE421100BDQ52354371-C3616F2F-D041-4511-A247-2DE245C8A89BQ52591511-A46A7847-554F-4ED7-B70B-211B0343D5ADQ58567942-248F388F-B22E-4FCB-B847-D6E190F69272Q59149655-09CC78AD-2AF0-4D54-9A4F-0D3BE2FAA64DQ59149657-88665431-2118-49B1-BBCC-BA977931E3ACQ59149662-030679DE-3B83-4FAF-AD66-02E0DFB4DB14Q59149666-9387642D-55F9-41B5-9134-25FB9BCEDBF2Q59149668-7BFAED94-7A1C-465E-B9C9-BA7CC7C21807
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marie B D'hooghe
@ast
Marie B D'hooghe
@en
Marie B D'hooghe
@es
Marie B D'hooghe
@fr
Marie B D'hooghe
@nl
Marie B D'hooghe
@sl
type
label
Marie B D'hooghe
@ast
Marie B D'hooghe
@en
Marie B D'hooghe
@es
Marie B D'hooghe
@fr
Marie B D'hooghe
@nl
Marie B D'hooghe
@sl
prefLabel
Marie B D'hooghe
@ast
Marie B D'hooghe
@en
Marie B D'hooghe
@es
Marie B D'hooghe
@fr
Marie B D'hooghe
@nl
Marie B D'hooghe
@sl
P106
P1153
6701414696
P21
P31
P496
0000-0002-0917-4176